'Huge leap' in prostate cancer tests may prevent 25,000 biopsies
MRI scan discovered to be more efficient in identifying dangerous tumours
A simple scan could help doctors catch and diagnose prostate cancer without the need for biopsies, according to a new study.
Trial results published in The Lancet say an MRI can pick up 93 per cent of aggressive cancers, while biopsies only find 48 per cent and can often miss the tumour altogether.
Scans were also shown to be better at ruling out cancer, as well as identifying benign tumours, a finding that could greatly reduce the number of men having invasive surgery.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Dr Philip Haslam, the chairman of the British Society of Urogenital Radiology, said the findings "represent a huge leap forward in prostate cancer diagnosis".
According to the BBC, the NHS is reviewing whether the scans can be introduced widely, although the cost could be a drawback. Experts also say the limited number of scanners could present a significant obstacle in rolling out the tests across the country
Around 100,000 men in Britain are sent for a biopsy each year after blood tests suggesting they may have prostate cancer, says the Daily Telegraph.
The trial by Prostate MRI Imaging Study, led by researchers at University College London, showed that more than a quarter of them could be spared the procedure.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Patients who undergo a biopsy often do not have an aggressive tumour, or any form of cancer, and run the risk of developing urinary problems or even sepsis as a result of the unnecessary surgery.
Angela Culhane, chief executive of Prostate Cancer UK, said the current system of diagnosis was "notoriously imperfect" and described the new findings as "the biggest leap forward in prostate cancer diagnosis in decades".
-
Bolton indictment: Retribution or justice?Feature Trump’s former national security adviser turned critic, John Bolton, was indicted for mishandling classified information after publishing his ‘tell-all’ memoir
-
Chicago: Scenes from a city under siegeFeature Chicago is descending into chaos as masked federal agents target people in public spaces and threaten anyone who tries to document the arrests
-
Young Republicans: Does the GOP have a Nazi problem?Feature Leaked chats from members of the Young Republican National Federation reveal racist slurs and Nazi jokes
-
Home Office worker accused of spiking mistress’s drink with abortion drugSpeed Read Darren Burke had failed to convince his girlfriend to terminate pregnancy
-
In hock to Moscow: exploring Germany’s woeful energy policySpeed Read Don’t expect Berlin to wean itself off Russian gas any time soon
-
Were Covid restrictions dropped too soon?Speed Read ‘Living with Covid’ is already proving problematic – just look at the travel chaos this week
-
Inclusive Britain: a new strategy for tackling racism in the UKSpeed Read Government has revealed action plan setting out 74 steps that ministers will take
-
Sandy Hook families vs. Remington: a small victory over the gunmakersSpeed Read Last week the families settled a lawsuit for $73m against the manufacturer
-
Farmers vs. walkers: the battle over ‘Britain’s green and pleasant land’Speed Read Updated Countryside Code tells farmers: ‘be nice, say hello, share the space’
-
Motherhood: why are we putting it off?Speed Read Stats show around 50% of women in England and Wales now don’t have children by 30
-
Anti-Semitism in America: a case of double standards?Speed Read Officials were strikingly reluctant to link Texas synagogue attack to anti-Semitism